海顺新材(300501) - 2022 Q1 - 季度财报

Financial Performance - Revenue for Q1 2022 was CNY 231,871,055.84, an increase of 3.57% compared to CNY 223,874,529.01 in the same period last year[4] - Net profit attributable to shareholders decreased by 24.13% to CNY 25,483,174.76 from CNY 33,586,697.68 year-on-year[4] - Basic earnings per share fell by 38.10% to CNY 0.13 from CNY 0.21 in the same period last year[4] - The net profit for Q1 2022 was CNY 27,050,277.66, a decrease of 21.1% from CNY 34,217,622.40 in Q1 2021[24] - The profit attributable to the parent company's shareholders was CNY 25,483,174.76, down 24.2% from CNY 33,586,697.68 in the previous year[24] - The total comprehensive income for the first quarter was CNY 27,050,277.66, a decrease from CNY 34,217,622.40 in the previous year, representing a decline of approximately 21%[25] Cash Flow and Liquidity - Net cash flow from operating activities was negative at CNY -39,061,737.17, a decline of 209.64% compared to CNY 35,626,124.72 in the previous year[4] - Cash inflow from operating activities totaled CNY 179,921,854.94, down from CNY 219,412,068.25, indicating a decrease of about 18%[27] - The company reported cash outflows from operating activities of CNY 218,983,592.11, an increase of approximately 19% from CNY 183,785,943.53 in the previous year[27] - The cash and cash equivalents at the end of the period were CNY 435,806,092.42, a significant increase of 358.06% from CNY 95,140,921.56 at the end of the previous year[9] - The company reported cash and cash equivalents of ¥457,017,550.08 at the end of the period, down from ¥633,853,715.33 at the beginning of the year[17] Assets and Liabilities - Total assets increased by 2.35% to CNY 2,317,309,669.68 from CNY 2,264,050,337.46 at the end of the previous year[4] - The total liabilities increased to CNY 697,322,406.15, up from CNY 678,549,169.20, representing a rise of 2.3%[19] - The inventory level was CNY 162,539,558.44, slightly up from CNY 160,744,669.02, showing a marginal increase of 1.1%[18] Investment Activities - Investment activities generated a net cash outflow of CNY -129,754,726.70, an increase of 103.68% compared to CNY -63,704,263.81 in the previous year[9] - The total cash inflow from investment activities was CNY 36,485,924.01, down from CNY 55,361,561.05, indicating a decline of about 34%[27] Shareholder Information - Total number of common shareholders at the end of the reporting period is 14,934[11] - The largest shareholder, Lin Wuhui, holds 29.98% of shares, totaling 58,019,499 shares, with 9,800,000 shares pledged[11] - The top ten shareholders include Zhu Xiumei with 16.65% ownership, totaling 32,230,408 shares[11] - The total number of restricted shares at the end of the period is 68,494,869, with 1,379,250 shares released and 429,750 shares newly restricted during the period[15] - The company has a total of 69,444,369 restricted shares, with various executives holding significant amounts[15] Operational Insights - The company is focused on expanding its market presence and developing new products in the pharmaceutical packaging sector[12] - The management emphasizes the importance of innovation in product development to maintain competitive advantage[12] - The company plans to continue its strategy of shareholder engagement and potential future capital raises[12] Costs and Expenses - The total operating costs for Q1 2022 amounted to CNY 201,369,862.48, up 8.5% from CNY 185,596,469.38 year-over-year[22] - Research and development expenses for Q1 2022 were CNY 7,732,996.71, an increase of 26.0% from CNY 6,138,998.03 in the same period last year[22] - The company reported a financial cost of CNY -1,904,352.15, which is a decrease compared to CNY -803,402.29 in the previous year, indicating improved financial management[22] - The company reported a significant increase in cash paid for purchasing goods and services, totaling CNY 151,465,112.46, compared to CNY 127,487,870.31 in the previous year, an increase of approximately 19%[27] Credit and Impairment - The company experienced a 2959.03% increase in credit impairment losses, amounting to CNY -1,901,408.34, primarily due to increased bad debt provisions[8]